SR4 also prevented hepatic steatosis in HFD mice, concomitant with decreased liver lipid triglycerides, increased leptin and decreased adiponectin levels, and normalization of liver enzymes ALT and AST. This evidence concerns the gene ADIPOQ and Hepatic steatosis.